...
首页> 外文期刊>Journal of Medicinal Chemistry >Successful virtual screening for a submicromolar antagonist of the neurokinin-1 receptor based on a ligand-supported homology model
【24h】

Successful virtual screening for a submicromolar antagonist of the neurokinin-1 receptor based on a ligand-supported homology model

机译:基于配体支持的同源性模型成功地虚拟筛选神经激肽-1受体的亚微摩尔拮抗剂

获取原文
获取原文并翻译 | 示例

摘要

The neurokinin-1 (NK1) receptor belongs to the family of G-protein-coupled receptors (GPCRs), which represents one of the most relevant target families in small-molecule drug design. In this paper, we describe a homology modeling of the NK1 receptor based on the high-resolution X-ray structure of rhodopsin and the successful virtual screening based on this protein model. The NK1 receptor model has been generated using our new MOBILE (modeling binding sites including ligand information explicitly) approach. Starting with preliminary homology models, it generates improved models of the protein binding pocket together with bound ligands. Ligand information is used as an integral part in the homology modeling process. For the construction of the NK1 receptor, antagonist CP-96345 was used to restrain the modeling. The quality of the obtained model was validated by probing its ability to accommodate additional known NK1 antagonists from structurally diverse classes. On the basis of the generated model and on the analysis of known NK1 antagonists, a pharmacophore model was deduced, which subsequently guided the 2D and 3D database search with UNITY. As a following step, the remaining hits were docked into the modeled binding pocket of the NK1 receptor. Finally, seven compounds were selected for biochemical testing, from which one showed affinity in the submicromolar range. Our results suggest that ligand-supported homology models of GPCRs may be used as effective platforms for structure-based drug design.
机译:Neurokinin-1(NK1)受体属于G蛋白偶联受体(GPCR)家族,它代表小分子药物设计中最相关的靶标家族之一。在本文中,我们基于视紫红质的高分辨率X射线结构描述了NK1受体的同源性模型,并基于该蛋白模型成功进行了虚拟筛选。 NK1受体模型是使用我们新的MOBILE(显式建模包含配体信息的结合位点)方法生成的。从初步的同源模型开始,它生成了蛋白质结合口袋和结合的配体的改进模型。配体信息被用作同源性建模过程的组成部分。对于NK1受体的构建,使用拮抗剂CP-96345来限制建模。通过探测其容纳结构上不同类别的其他已知NK1拮抗剂的能力来验证所获得模型的质量。根据生成的模型并分析已知的NK1拮抗剂,推导了药效团模型,随后用UNITY指导2D和3D数据库搜索。接下来的步骤是,将其余的命中位点连接到NK1受体的模型结合口袋中。最后,选择了7种化合物进行生化测试,其中一种显示出在亚微摩尔范围内的亲和力。我们的结果表明,GPCR的配体支持同源性模型可用作基于结构的药物设计的有效平台。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号